Trehalose for Skin

Besides An Essential Skin Care Ingredient, Trehalose Can Do More!

• 2020-09-14
  

  The largest trehalose project in Asia was put into construction

  It is understood that the grain and oil giant Cargill and its partners are building a 50,000-ton (the largest in Asia) trehalose project, which is expected to be put into operation in June next year; in addition, the company is also investing in the construction of a flavored syrup production line in Pinghu, Zhejiang, to provide different products to the market. Standard sugar substitute and compound sugar solutions, serving downstream milk tea shops and catering companies.
  trehalose project sugar substitute
• 2020-08-19
  

  Glycosyltransferase applied to trehalose production technology breakthrough

  Recently, the sugar alcohol plant of Shandong Tianli Pharmaceutical Co., Ltd. succeeded in its self-produced glycosyltransferase production scale-up experiment and realized its application in the production of trehalose, reducing the production cost of trehalose by more than 500 yuan per ton.In 2019, the R&D Center of Tianli Pharmaceutical Co., Ltd. used genetic engineering technology to construct a glycosyltransferase-producing strain. In July of this year, the company will conduct scale-up experiments for its self-produced glycosyltransferase in trehalose production. After adjusting the key process control parameters and the amount of enzyme preparation in the enzyme production fermentation section and the sugar chemical section, they applied the self-produced glycosyltransferase in the one-step saccharification of trehalose, and the saccharification conversion rate fully met the process requirements.At present, the company's annual production capacity of trehalose is 10,000 tons. After the successful application of self-produced glycosyltransferase in trehalose production, the company can increase its annual profit by more than 5 million yuan.
  Glycosyltransferase trehalose production technology
• 2025-09-11
  

  Premium Global Chemical Sourcing Requests (6-11 Sep 2025)

  ECHEMI.com curates procurement needs from high-quality chemical companies worldwide. This issue summarizes procurement information for seven companies in Saudi Arabia, the United States, Portugal, the United Kingdom, and the Netherlands. These companies source products such as 1,3-butadiene, D(+)-trehalose dihydrate, and 1,3-pentadiene.
  ECHEMI high quality inquiries
• 2024-06-20
  

  Hi & Fi Asia-China 2024: ECHEMI's customized digital solutions for the food industry attract countless attention

  ECHEMI brought popular products in the food industry to customers, including astaxanthin, spirulina, collagen, turmeric, xanthan gum, pectin, citric acid monohydrate, trehalose, potassium sorbate and glycine, covering seven categories of extracts, joint bone supplements, thickeners, acidulants, sweeteners, preservatives, amino acids and vitamins. Not only that, the 22,000 suppliers on the ECHEMI platform quoted online and provided product information to buyers at any time.
  Hi & Fi Asia-China 2024 food ingredients
• 2024-05-06
  

  DKSH signs distribution agreement with India's TdB Labs

  TdB Labs' product portfolio includes dextran derivatives, fluorescent and non-fluorescent polysaccharide derivatives, as well as derivatives of other polysaccharides such as polysucrose, inulin, hyaluronic acid, trehalose and hydroxyethyl starch. Application areas include permeability, drug delivery, biomaterials and colitis research as well as applications in clinical product processing. TdB Labs' polysaccharide derivatives are also used in diagnostic kits and as molecular markers, while dextran sulfate is used as an anti-caking agent in cell culture media.
  DKSH TdB Labs
• 2024-04-19
  

  Breakthrough: China's First Profitable Biotech Emerges in 2024

  The success of SinoCellTech's recombinant VIII factor product can be attributed to two key factors. Firstly, the scarcity of plasma-derived VIII factor supply fueled the demand for recombinant VIII factor. With components such as mannitol, histidine, trehalose, and calcium chloride, recombinant VIII factor can be sold at prices ranging from 2,600 to 3,000 yuan per 1000IU, ensuring substantial profit margins. Secondly, the production of recombinant VIII factor is renowned as one of the most challenging endeavors in biopharmaceutical manufacturing, necessitating advanced technology and processes. SinoCellTech's SCT8000 project took nearly 15 years from initiation to market launch, including over 5 years of clinical trials and close to 2 years of regulatory approval. The company's exceptional profitability provided substantial support for increased research and development investments, enabling SinoCellTech to achieve profitability in its third full fiscal year following the commercialization of its flagship product.